Rapt Therapeutics Inc (RAPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPT | INZY | IVVD | ||
| Company | Rapt Therapeutics Inc | Inozyme Pharma Inc | Invivyd Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.28 | 4.75 | 2.39 | ||
| High | 8.58 | 4.84 | 2.54 | ||
| Low | 8.15 | 4.68 | 2.39 | ||
| Last | 8.33 | 4.74 | 2.42 | ||
| Change | +0.20 | +0.09 | +0.05 | ||
| % Change | +2.52% | +1.94% | +2.11% | ||
| Volume | 587,500 | 327,000 | 345,400 | ||
| 20-Day Average Volume | 849,795 | 761,240 | 861,420 | ||
| Previous Close | 8.13 | 4.65 | 2.37 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.24 | 4.75 | 2.50 | ||
| 20-Day Raw Stochastic | 37.96% | 19.79% | 31.12% | ||
| 20-Day Relative Strength | 42.40% | 42.94% | 41.50% | ||
| Weighted Alpha | -5.24 | -18.77 | -11.04 | ||
| Today's Opinion | 88% Sell | 8% Buy | 56% Sell | ||
| Previous Opinion | 100% Sell | 8% Sell | 56% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.84% since 04/26/24 | +6.76% since 04/26/24 | +12.56% since 04/26/24 | ||
| Low | 7.68 on 04/30/24 | 4.35 on 05/01/24 | 2.06 on 04/29/24 | ||
| High | 8.58 on 05/03/24 | 4.84 on 05/03/24 | 2.54 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -0.36% since 04/03/24 | -33.89% since 04/03/24 | -38.42% since 04/03/24 | ||
| Low | 7.52 on 04/25/24 | 4.18 on 04/25/24 | 2.00 on 04/25/24 | ||
| High | 9.65 on 04/11/24 | 7.31 on 04/04/24 | 3.98 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | -66.57% since 02/02/24 | -10.73% since 02/02/24 | -48.51% since 02/02/24 | ||
| Low | 6.86 on 02/20/24 | 4.18 on 04/25/24 | 2.00 on 04/25/24 | ||
| High | 27.35 on 02/12/24 | 7.80 on 04/01/24 | 5.10 on 02/08/24 | ||
| 6-Month | |||||
| %Chg | -46.26% since 11/03/23 | +49.06% since 11/03/23 | +59.21% since 11/03/23 | ||
| Low | 6.86 on 02/20/24 | 2.71 on 11/13/23 | 1.37 on 11/13/23 | ||
| High | 27.35 on 02/12/24 | 7.80 on 04/01/24 | 5.20 on 01/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 289,884 | 293,197 | 288,515 | ||
| Shares Outstanding, K | 34,800 | 61,856 | 119,221 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -116,800,000 | -71,170,000 | -198,640,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -30,880,000 | -21,540,000 | -73,650,000 | ||
| 60-Month Beta | 0.52 | 1.54 | 0.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.80 on 03/07/24 | -0.35 on 03/12/24 | -0.67 on 03/28/24 | ||
| Latest Earnings Date | 05/09/24 | 05/14/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||